Frammistaða Landspítala í forvörnum gegn bláæðasegasjúkdómum; þversniðsrannsókn á bráðadeildum

• Main Authors: Hallgerður Lind Kristjánsdóttir, Guðný Stella Guðnadóttir, Sigríður Bára Fjalldal, Hulda Rósa Þórarinsdóttir, Agnar Bjarnason, Óskar Einarsson
• Other Authors: Department of Medicine, Landspitali - University Hospital
• Format: Article in Journal/Newspaper
• Language: Icelandic
• Published: Læknafélag Íslands, Læknafélag Reykjavíkur 2012
• Subjects: Forvarnir (sjúkdómar); Bláæðasegasjúkdómar; Blóðsegasjúkdómar; Bráðalækningar; Adult; Aged; 80 and over; Cross-Sectional Studies; Female; Fibrinolytic Agents; Guideline Adherence; Hospital Units; Hospitals; University; Humans; Iceland; Male; Middle Aged; Patient Safety; Physician's Practice Patterns; Practice Guidelines as Topic; Treatment Outcome; Venous Thromboembolism; Smella
• Online Access: http://hdl.handle.net/2336/238257

Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Allur texti - Full text OBJECTIVE: Venous thromboembolic disease is a serious and often fatal complication following hospital admission. Studies show that thromboprophylactic therapy for this condition is often underutilized. The aim of this study was to evaluate the performance of thromboprophylactic therapy at Landspítali - The University Hospital of Iceland in adult patients admitted to acute wards. METHODS AND MATERIALS: On 2 December 2009 hospital charts of admitted patients on acute wards were reviewed and assessed for appropriate thromboprophylactic treatment according to the 2008 guidelines from The American College of Chest Physicians. The results were compared to those of other countries from the multinational Endorse study from 2008. RESULTS: 251 patient were included of whom 47% were considered at risk for venous thromboembolic disease. Of those 57% received appropriate thromboprophylactic treatment or 78% of surgical and 26% of medical patients. CONCLUSIONS: Adherence to clinical guidelines for thromboprophylactic treatment at surgical wards of Landspítali - The National University Hospital of Iceland was good and well above the average compared to the results of the Endorse study. Performance on the medical wards was on the other hand below average. Our results show that application of thromoboprophylactic treatment at Landspítali could be improved and thereby enhance patient safety. Tilgangur: Bláæðasegasjúkdómar eru alvarlegir og geta verið banvænir fylgikvillar sjúkrahúsinnlagna. Erlendar rannsóknir sýna að forvarnarmeðferð gegn bláæðasegum er víða ábótavant. Markmið þessarar rannsóknar var að meta frammistöðu Landspítala í forvörnum gegn bláæðasegasjúkdómum hjá inniliggjandi sjúklingum á bráðadeildum fullorðinna. Efniviður og aðferðir: Þann 2. desember 2009 var farið yfir sjúkraskrár allra inniliggjandi sjúklinga bráðadeilda Landspítala. Kannað var hvort viðkomandi fengi fyrirbyggjandi meðferð ...